Dorsavi Ltd

ASX:DVL ISIN:AU000000DVL0

dorsaVi (ASX:DVL) is an ASX company focused on developing innovative motion analysis device technologies for use in elite sports, occupational health and safety and clinical applications. dorsaVi believes its wearable sensor technology enables – for the first time – many aspects of detailed human movement and position to be accurately captured, quantified, and assessed outside a biomechanics lab, in both real-time and real situations for up to 24 hours.

Our technology has applications across three sectors:

- Clinical: ViMove is transforming the management of patients by providing objective assessment, monitoring outside the clinic and immediate biofeedback. ViMove is currently used by medical and physiotherapy practices in Australia, the United Kingdom, and the United States.

- Elite Sports: ViPerform is allowing coaches and medical teams managing elite athletes and teams to screen athletes and provide objective evidence for decisions on return to play, measure biomechanics and provide immediate biofeedback out on the field, tailor and track training programs and optimise technique and peak performance. ViPerform is being used by AFL and NRL clubs, Cricket Australia, and the Australian Institute of Sport (AIS) in Australia.  Barclays Premier League (EPL) clubs in the UK and US based sports clubs from the National Basketball Association (NBA), the Major Soccer League (MLS) and the National Football League (NFL) as well as various Olympic teams and athletes internationally.

- OHS: We combine innovation, measurement, and quality to reduce workplace incidents, costs, meet compliance and improve brand reputation. ViSafe enables employers to assess risk of injury for employees as well as test the effectiveness of proposed changes to workplace design, equipment or methods based on objective evidence. ViSafe has been used by major corporations including Sodexo, London Underground, Vinci Construction, Crown Resorts, Caterpillar (US), Monash Health, Coles, Woolworths, Toll, Toyota, Orora (formerly Amcor), Crown and BHP Billiton. Australian Workplace Compliance delivers risk mitigation through compliance to OHS, Quality Management Systems, Company Policy, and Process.

Further information is available at http://www.dorsavi.com

 
     

News

dorsaVi (ASX:DVL) Receives $1.1m Federal Government Advanced Manufacturing Growth Fund Grant to Support Enhancements to Current Manufacturing Facilities

🕔10/18/2017 1:21:57 PM 6285

dorsaVi (ASX:DVL) is pleased to announce it has received a Federal Government Advanced Manufacturing Growth Fund grant of more than $1.1m. This Federal fund was established to help industry adjust to the wind-down of car manufacturing in Victoria and South Australia. The fund is focused on advanced manufacturing activities that will boost innovation, skills and employment opportunities.

Read Full Article

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 12083

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article
###

3,710 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 5) (Last 30 Days: 30) (Since Published: 3710) 

Company Data

    Headquarters
  • Level 1, 120 Jolimont Road
    East Melbourne
    Victoria 3002
    Australia
  • Telephone
  • +61-3-9652-2198 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage
  • http://www.dorsavi.com

More News Results

  • 2024/04/18: Notification regarding unquoted securities - DVL*
  • 2024/04/16: dorsaVi enters aged care market with natural movement AI*
  • 2024/04/15: Final Director's Interest Notice*
  • 2024/04/15: Non-executive Director resignation*
  • 2024/04/08: dorsaVi releases video AI for upper limb tracking*
  • 2024/03/18: DVL adds real-time facial tracking to AI-powered platform*
  • 2024/03/15: Initial Director's Interest Notice*
  • 2024/03/15: Final Director's Interest Notice*
  • 2024/03/13: Dr Attia to retire, Gernot Abl appointed to dorsaVi Board*
  • 2024/03/01: Cancellation of Performance Rights*
*refer to company website

Social Media